Pharmaceutical and dietetic products, namely, biotherapies comprising cells for medical or clinical use; medicines for use in treating cardiometabolic risk factors, cardiovascular diseases, obesity, pre-diabetes, type-2 diabetes, hepatic steatosis, metabolic diseases, inflammatory diseases, chronic inflammatory bowel diseases, dysbiosis, dysbiosis of the intestinal microbiota; medicines for prevention and treatment of cardiometabolic risk factors, cardiovascular diseases, obesity, pre-diabete...